The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
A review on cholinesterase inhibitors for Alzheimer’s disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tacrine for Alzheimer's disease
Qizilbash, N., Birks, J., Arrieta, J. L., Lewington, S., & Szeto, S. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000202 · Cited by 85
RetractedKnapp, M. J. (1994) · JAMA · doi:10.1001/jama.271.13.985 · Cited by 1,004
Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase.
Harel, M., Schalk, I., Ehret-Sabatier, L., Bouet, F., Goeldner, M., Hirth, C., Axelsen, P. H., Silman, I., & Sussman, J. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9031 · Cited by 899
Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease
Watkins, P. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370044030 · Cited by 829
(1994) · Pharmaceutical Design And Development · doi:10.1201/b12597-9 · Cited by 784
Kryger, G., Silman, I., & Sussman, J. L. (1999) · Structure · doi:10.1016/s0969-2126(99)80040-9 · Cited by 757
Mesulam, M.-M., Guillozet, A., Shaw, P., Levey, A., Duysen, E. G., & Lockridge, O. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00613-3 · Cited by 650
β-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies
Bartolini, M., Bertucci, C., Cavrini, V., & Andrisano, V. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01514-9 · Cited by 568
A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes
Tomás‐Zapico, C., & Coto‐Montes, A. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2005.00248.x · Cited by 503
Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site
Bourne, Y. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg005 · Cited by 488
(2010) · Acta Pharmacologica Sinica · doi:10.1111/(issn)1745-7254 · Cited by 479
A Structural Motif of Acetylcholinesterase That Promotes Amyloid β-Peptide Fibril Formation
De Ferrari, G. V., Canales, M. A., Shin, I., Weiner, L. M., Silman, I., & Inestrosa, N. C. (2001) · Biochemistry · doi:10.1021/bi0101392 · Cited by 413
Protection against β‐amyloid peptide toxicity in vivo with long‐term administration of ferulic acid
Yan, J., Cho, J., Kim, H., Kim, K., Jung, J., Huh, S., Suh, H., Kim, Y., & Song, D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704047 · Cited by 364
Highly Potent, Selective, and Low Cost Bis-tetrahydroaminacrine Inhibitors of Acetylcholinesterase
Pang, Y.-P., Quiram, P., Jelacic, T., Hong, F., & Brimijoin, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.23646 · Cited by 344
Coumarins Derivatives as Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase
Brühlmann, C., Ooms, F., Carrupt, P.-A., Testa, B., Catto, M., Leonetti, F., Altomare, C., & Carotti, A. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010894d · Cited by 290
Lipoic acid as a novel treatment for Alzheimer's disease and related dementias
Holmquist, L., Stuchbury, G., Berbaum, K., Muscat, S., Young, S., Hager, K., Engel, J., & Münch, G. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.07.001 · Cited by 288
Acetylcholinesterase Inhibition by Flavonoids from Agrimonia pilosa
Jung, M., & Park, M. (2007) · Molecules · doi:10.3390/12092130 · Cited by 270
Piazzi, L., Rampa, A., Bisi, A., Gobbi, S., Belluti, F., Cavalli, A., Bartolini, M., Andrisano, V., Valenti, P., & Recanatini, M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0340602 · Cited by 266
Rodríguez-Franco, M. I., Fernández-Bachiller, M. I., Pérez, C., Hernández-Ledesma, B., & Bartolomé, B. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050746d · Cited by 248
Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish
Richetti, S. K., Blank, M., Capiotti, K. M., Piato, A. L., Bogo, M. R., Vianna, M. R., & Bonan, C. D. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.09.027 · Cited by 248
Sterling, J., Herzig, Y., Goren, T., Finkelstein, N., Lerner, D., Goldenberg, W., Miskolczi, I., Molnar, S., Rantal, F., Tamas, T., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020120c · Cited by 247
Rational Approach To Discover Multipotent Anti-Alzheimer Drugs
Rosini, M., Andrisano, V., Bartolini, M., Bolognesi, M. L., Hrelia, P., Minarini, A., Tarozzi, A., & Melchiorre, C. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049112h · Cited by 226
Nitric oxide and nitroxidative stress in Alzheimer's disease
Malinski, T. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11208 · Cited by 220 · cited 2×
“Nitric oxide (NO) plays an important role in the physiological processes at the CNS level (Malinski 2007) and NO donors/NO mimetic produce beneficial effects in AD (Thatcher et al. 2005).”
BackgroundMuñoz-Ruiz, P., Rubio, L., García-Palomero, E., Dorronsoro, I., del Monte-Millán, M., Valenzuela, R., Usán, P., de Austria, C., Bartolini, M., Andrisano, V., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0503289 · Cited by 219
Piazzi, L., Cavalli, A., Colizzi, F., Belluti, F., Bartolini, M., Mancini, F., Recanatini, M., Andrisano, V., & Rampa, A. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.09.100 · Cited by 214
Selective inhibition of human acetylcholinesterase by galanthamine in vitro and in vivo
Thomsen, T., & Kewitz, H. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90429-u · Cited by 207
Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex
Rees, T. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00230-0 · Cited by 207
Structural Aspects of Flavonoids as Inhibitors of Human Butyrylcholinesterase
Katalinić, M., Rusak, G., Domaćinović Barović, J., Šinko, G., Jelić, D., Antolović, R., & Kovarik, Z. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.09.041 · Cited by 206
Camps, P., Formosa, X., Galdeano, C., Gómez, T., Muñoz-Torrero, D., Scarpellini, M., Viayna, E., Badia, A., Clos, M. V., Camins, A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8001313 · Cited by 205
Deciphering the genesis and fate of amyloid β-protein yields novel therapies for Alzheimer disease
Selkoe, D. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16783 · Cited by 204
Design and synthesis of tacrine–ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates
Fang, L., Kraus, B., Lehmann, J., Heilmann, J., Zhang, Y., & Decker, M. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.03.073 · Cited by 190
Rosini, M., Simoni, E., Bartolini, M., Cavalli, A., Ceccarini, L., Pascu, N., McClymont, D. W., Tarozzi, A., Bolognesi, M. L., Minarini, A., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800577j · Cited by 185
The pharmacology of galanthamine and its analogues
Harvey, A. L. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)02002-0 · Cited by 169
Fernández‐Bachiller, M. I., Pérez, C., Campillo, N. E., Páez, J. A., González‐Muñoz, G. C., Usán, P., García‐Palomero, E., López, M. G., Villarroya, M., García, A. G., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200800414 · Cited by 159
Castro, A., & Martinez, A. (2001) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557013406864 · Cited by 159
Donepezil–tacrine hybrid related derivatives as new dual binding site inhibitors of AChE
Alonso, D. A., Dorronsoro, I., Rubio, L., Muñoz, P., García‐Palomero, E., del Monte, M., Bidon‐Chanal, A., Orozco, M., Luque, F. J., Castro, A., et al. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.09.029 · Cited by 158
Melatonin role in the mitochondrial function
Acuña-Castroviejo, D. (2006) · Frontiers in bioscience · doi:10.2741/2116 · Cited by 157
Design, Synthesis, and Biological Evaluation of Conformationally Restricted Rivastigmine Analogues
Bolognesi, M. L., Bartolini, M., Cavalli, A., Andrisano, V., Rosini, M., Minarini, A., & Melchiorre, C. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049782n · Cited by 147
Savini, L., Gaeta, A., Fattorusso, C., Catalanotti, B., Campiani, G., Chiasserini, L., Pellerano, C., Novellino, E., McKissic, D., & Saxena, A. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0255668 · Cited by 146
Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues
Zhou, X. Y., Wang, X., Wang, T., & Kong, L. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.07.068 · Cited by 143
Pharmacological drug treatment of Alzheimer disease: The cholinergic hypothesis revisited
Ladner, C. J., & Lee, J. M. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199808000-00001 · Cited by 142
Marco, J. L., Leon, R. M., Ríos, C. D. L., Samadi, A., Bartolini, M., Andrisano, V., Huertas, Ó., Barril, X., Luque, F. J., Rodríguez-Franco, M. I., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801292b · Cited by 137
Bolognesi, M. L., Andrisano, V., Bartolini, M., Banzi, R., & Melchiorre, C. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049156q · Cited by 136
Howlett, D. R., George, A. R., OWEN, D. E., Ward, R. V., & Markwell, R. E. (1999) · Biochemical Journal · doi:10.1042/bj3430419 · Cited by 133
Howlett, D. R., George, A. R., OWEN, D. E., Ward, R. V., & Markwell, R. E. (1999) · PubMed Central · Cited by 123
Marco, J. L., Leon, R. M., Ríos, C. D. L., Guglietta, A., Terencio, J. V., López, M. G., García, A. G., & Villarroya, M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm061047j · Cited by 118
Barreiro, E. J., Câmara, C. A., Verli, H., Brazil-Más, L., Castro, N. G., Cintra, W. M., Aracava, Y., Rodrigues, C. R., & Fraga, C. A. M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020391n · Cited by 113
Novel Benzisoxazole Derivatives as Potent and Selective Inhibitors of Acetylcholinesterase
Villalobos, A., Blake, J. F., Bíggers, C. K., Butler, T. W., Chapin, D. S., Chen, Y. L., Ives, J. L., Jones, S. B., & Liston, D. R. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00043a012 · Cited by 112
Mary, A., Renko, D. Z., Guillou, C., & Thal, C. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(98)00133-3 · Cited by 108
Oxidative Stress in Alzheimer Patients in Different Stages of the Disease
Zafrilla, P., Mulero, J., Graupera, J. M. X., Santo, E., Caravaca, G., & Morillas, J. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776360978 · Cited by 105
Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease
Бачурин, С. О. (2002) · Medicinal Research Reviews · doi:10.1002/med.10026 · Cited by 100
Belluti, F., Rampa, A., Piazzi, L., Bisi, A., Gobbi, S., Bartolini, M., Andrisano, V., Cavalli, A., Recanatini, M., & Valenti, P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049515h · Cited by 97
Uçar, G., Gökhan, N., Yeşilada, A., & Bilgin, A. A. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.028 · Cited by 97
Kato, K., Hayako, H., Ishihara, Y., Marui, S., Iwane, M., & Miyamoto, M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00943-4 · Cited by 95
Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors
Shen, Q., Peng, Q., Shao, J., Liu, X., Huang, Z., Pu, X., Ma, L., Li, Y., Chan, A. S. C., & Gu, L. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2005.07.014 · Cited by 93
Isolation of Cholinesterase-Inhibiting Flavonoids from Morus lhou
Kim, J. Y., Lee, W. S., Kim, Y. S., Long, M. J. C., Lee, B. W., Ryu, Y. B., & Park, K. H. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf200423g · Cited by 93
Marco, J. L., Rı́os, C. D. L., Garcı́a, A. G., Villarroya, M., Carreiras, M. C., Martins, C., Eleutério, A., Morreale, A., Orozco, M., & Luque, F. J. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.02.017 · Cited by 91
Gottwald, M. D., & Rozanski, R. I. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.10.1673 · Cited by 91
Toda, N., Tago, K., Marumoto, S., Takami, K., Ori, M., Yamada, N., Koyama, K., Naruto, S., Abe, K., Yamazaki, R., et al. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00452-8 · Cited by 90
Guillou, C., Mary, A., Renko, D. Z., Gras, E., & Thal, C. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00059-7 · Cited by 88
Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease
Geula, C., & Darvesh, S. (2004) · Drugs of today · doi:10.1358/dot.2004.40.8.850473 · Cited by 88
Piazzi, L., Cavalli, A., Belluti, F., Bisi, A., Gobbi, S., Rizzo, S., Bartolini, M., Andrisano, V., Recanatini, M., & Rampa, A. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070100g · Cited by 87
Meng, F.-C., Mao, F., Shan, W., Qin, F., Huang, L., & Li, X. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.029 · Cited by 86
Colombres, M., Sagal, J. P., & Inestrosa, N. C. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383359 · Cited by 84
Melchiorre, C., Andrisano, V., Bolognesi, M. L., Budriesi, R., Cavalli, A., Cavrini, V., Rosini, M., Tumiatti, V., & Recanatini, M. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9810452 · Cited by 81
Huang, L., Su, T., Shan, W., Luo, Z., Sun, Y., He, F., & Li, X. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.02.059 · Cited by 80
Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors
Sheng, R., Lin, X., Zhang, J., Chol, K. S., Huang, W., Yang, B., He, Q., & Hu, Y. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.07.072 · Cited by 80
N-Benzylpiperidine derivatives of 1,2,4-thiadiazolidinone as new acetylcholinesterase inhibitors
Martı́nez, A., Fernandez, E., Castro, A., Conde, S., Rodrı́guez-Franco, M. I., Baños, J.-E., & Badı́a, A. (2000) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(00)01166-1 · Cited by 79
Inhibition of acetylcholinesterase by coumarins: The case of coumarin 106
Fallarero, A., Oinonen, P., GUPTA, S., BLOM, P., Galkin, A., Mohan, C. G., & Vuorela, P. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.08.001 · Cited by 79
Shao, D., Zou, C., Luo, C., Tang, X.-C., & Li, Y. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.07.005 · Cited by 75
Leon, R. M., Ríos, C. D. L., Marco, J. L., Huertas, Ó., Barril, X., Luque, F. J., López, M. G., García, A. G., & Villarroya, M. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.07.005 · Cited by 74
Design, synthesis and evaluation of galanthamine derivatives as acetylcholinesterase inhibitors
Jia, P. J., Sheng, R., Zhang, J., Fang, L., He, Q., Yang, B., & Hu, Y. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.04.018 · Cited by 70
Pisani, L., Catto, M., Giangreco, I., Leonetti, F., Nicolotti, O., Stefanachi, A., Cellamare, S., & Carotti, A. (2010) · ChemMedChem · doi:10.1002/cmdc.201000210 · Cited by 70
Piazzi, L., Belluti, F., Bisi, A., Gobbi, S., Rizzo, S., Bartolini, M., Andrisano, V., Recanatini, M., & Rampa, A. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.026 · Cited by 67
Andreani, A., Cavalli, A., Granaiola, M., Guardigli, M., Leoni, A., Locatelli, A., Morigi, R., Rambaldi, M., Recanatini, M., & Roda, A. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0109356 · Cited by 66
Mao, F., Huang, L., Luo, Z., Liu, A., Lu, C., Xie, Z., & Li, X. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.07.045 · Cited by 63
Marco, J. L., Rı́os, C. D. L., Carreiras, M. C., Baños, J.-E., Badı́a, A., & Vivas, N. M. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00284-4 · Cited by 63
The neuroprotective role of melatonin against amyloidβpeptide injected mice
Masilamoni, J. G., Jesudason, E. P., Dhandayuthapani, S., Ashok, B. S., Vignesh, S., Walter, C. E. J., Paul, S. F. D., & Rajadas, J. (2008) · Free Radical Research · doi:10.1080/10715760802277388 · Cited by 63
Sheng, R., Lin, X., Li, J., Jiang, Y., Shang, Z., & Hu, Y. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.05.132 · Cited by 63
Cappelli, A., Gallelli, A., Manini, M., Anzini, M., Mennuni, L., Makovec, F., Menziani, M. C., Alcaro, S., Ortuso, F., & Vomero, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0493461 · Cited by 62
Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans
Thomsen, T., Bickel, U., Fischer, J. P., & Kewitz, H. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00316106 · Cited by 62
Nitric Oxide Mimetic Molecules as Therapeutic Agents in Alzheimers Disease
Thatcher, G. R. J., Bennett, B. M., & Reynolds, J. N. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585945 · Cited by 60
Campiani, G., Fattorusso, C., Butini, S., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049510k · Cited by 59
Synthesis, acetylcholinesterase inhibition and neuroprotective activity of new tacrine analogues
Leon, R. M., Marco, J. L., Garcı́a, A. G., & Villarroya, M. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.11.020 · Cited by 54
Savini, L., Campiani, G., Gaeta, A., Pellerano, C., Fattorusso, C., Chiasserini, L., Fedorko, J. M., & Saxena, A. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00294-3 · Cited by 52
Tacrine for Alzheimer's Disease
Winker, M. A. (1994) · JAMA · doi:10.1001/jama.1994.03510370075036 · Cited by 47
Trujillo-Ferrara, J. G., Cano, L. M., & Espinoza-Fonseca, M. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00198-7 · Cited by 46
p–Aminobenzoic acid derivatives as acetylcholinesterase inhibitors
Correa‐Basurto, J., Alcántara, I. V., Espinoza-Fonseca, M., & Trujillo-Ferrara, J. G. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2005.03.011 · Cited by 44
Acetyl‐ and Butyryl‐cholinesterase Inhibitory Activities of Mansorins and Mansonones
Changwong, N., Sabphon, C., Ingkaninan, K., & Sawasdee, P. (2011) · Phytotherapy Research · doi:10.1002/ptr.3576 · Cited by 43
Synthesis and Biological Evaluation of Thiophene Derivatives as Acetylcholinesterase Inhibitors
Ismail, M., Kamel, M. M., Mohamed, L. W., Faggal, S. I., & Galal, M. A. (2012) · Molecules · doi:10.3390/molecules17067217 · Cited by 42
Lin, G., Lai, C., & Liao, W. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00213-8 · Cited by 41
Mustazza, C., Borioni, A., Giudice, M. R. D., GATTA, F., Ferretti, R., Meneguz, A., Volpe, M. T., & Lorenzini, P. (2002) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01324-1 · Cited by 40
Synthesis and structure–activity relationships of open D-Ring galanthamine analogues
Herlem, D., Martin, M., Thal, C., & Guillou, C. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00397-4 · Cited by 34
Hamuľaková, S., Janovec, L., Hrabinová, M., Kristián, P., Kuča, K., Baňasová, M., & Imrich, J. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.06.051 · Cited by 32
Trujillo-Ferrara, J. G., Vázquez, I., Espinosa, J., Santillan, R. L., Farfán, N., & Herbert Höpfl, B. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00023-x · Cited by 27
Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents.
Petroianu, G. A., Arafat, K., Sasse, B. C., & Stark, H. (2006) · PubMed · Cited by 25
Anand, P., & Singh, B. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0162-3 · Cited by 23
Self-citationLin, G., Tseng, H.-C., Chio, A.-C., Tseng, T.-M., & Tsai, B.-Y. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.12.058 · Cited by 13
Cited by
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Breijyeh, Z., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25245789 · Cited by 2,789
Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects
Rahman, M. M., Rahaman, M. S., Islam, M. R., Rahman, F., Mithi, F. M., Alqahtani, T., Almikhlafi, M. A., Alghamdi, S. Q., Alruwaili, A. S., Hossain, M. S., et al. (2021) · Molecules · doi:10.3390/molecules27010233 · Cited by 852
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
Schiff bases in medicinal chemistry: a patent review (2010-2015)
Hameed, A., al-Rashida, M., Uroos, M., Abid Ali, S., & Khan, K. M. (2017) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1252752 · Cited by 401
Santos, T. C. D., Gomes, T. M., Pinto, B. A. S., Camara, A. L., & Paes, A. M. D. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01192 · Cited by 389
Metadata
- Authors
- Anand, P., & Singh, B.
- Venue
- Archives of Pharmacal Research
- Published
- 2013-02-24
- Volume
- 36
- Issue
- 4
- Pages
- 375-399
- ISSN
- 0253-6269 (ISSN-L)
- 1976-3786
- OpenAlex
- W2047420624
- Cited by
- 709
- References
- 98
- FWCI
- 22.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.